Repligen started at buy by TD Cowen, limited NIH exposure cited
TD Cowen has started coverage of Repligen (NASDAQ:RGEN) with a buy rating, citing the company's limited exposure to NIH funding cuts and China. The investment bank said Repligen (NASDAQ:RGEN) was ...
Logistics Management57m
Looking at the freight transportation landscape with Jason Seidl, Managing Director, Industrials - Airfreight & Surface Transportation, TD Cowen
Logistics Management Group News Editor Jeff Berman recently interviewed Jason Seidl, Managing Director, Industrials - ...